Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.

Drug Derived From Caribbean Reefs May Treat Psoriasis, Ms | Fox News

Ease Psoriasis Pain: Ways to Find Relief During a Flare

Traditional treatments for autoimmune disorders suppress the entire immune system, putting patients at risk for infections. Phase 1 trials are preliminary, meant to test the safety and tolerability of a new drug in a small group of patients. The bulk of new drugs tested fail to advance to phase 2 trials, which test a products efficacy among a larger group. Autoimmune diseases affect as many as 23.5 million people in the U.S., especially women, according to the National Institutes of Health.
For the original version including any supplementary images or video, visit http://www.foxnews.com/health/2015/05/05/drug-derived-from-caribbean-reefs-may-treat-psoriasis-ms/

InPlay from Briefing.com - Yahoo Finance

psoriasis shampoo treatment Chief Executive Officer Robert J. Hugin said his partnerships with companies in the early stages of drug development are bearing fruit, yielding more than half of eight new compounds the company aims to put into human testing over the next 18 months. We think the strategy is working very well, Hugin said in an interview with Bloomberg News Friday in Shanghai. Theres great productivity coming out of the partnerships. As part of its plan to reduce its dependence on cancer drug Revlimid, Celgene struck 10 licensing deals in 2014, more than any other biotech company, according to Bloomberg Intelligence. The strategy provides biotech startups with capital and an experienced ally to help bring early-stage products to market. Celgenes alliance with Acceleron Pharma Inc. has yielded two different drugs that are currently in late-stage trials, while a collaboration with Agios Pharmaceuticals Inc. has produced one product that will soon begin a final-stage study that will be used too seek regulatory approval, Hugin said.
For the original version including any supplementary images or video, visit http://www.bloomberg.com/news/articles/2015-05-08/celgene-ceo-says-early-stage-partnerships-begin-to-show-promise

The company also sought approval for the treatments use in patients age 12 to 17, however the FDA issued a Complete Response Letter (CRL), requesting more data before opening up the treatment for this age group. Breo Ellipta was examined in 12,000 subjects ages 12 and up in 23 studies. Medicines Co. Blood-Clotting Agent Approved The FDA approved the homeostatic product Raplixa , a combination of fibrinogen and thrombintwo human plasma-derived blood-clotting proteins. The dry powder formulation, approved for use with a gelatin sponge, is indicated to stop bleeding during surgery when other blood-clotting agents fail. According to Reuters, analysts expect the drug to bring in $100 million in the U.S. Amerigen Given Tentative Nod For Toviaz The companys Abbreviated New Drug Application (ANDA) for its generic of Toviaz received a tentative approval from the FDA. The Pfizer-marketed brand name drug Toviaz (Fesoterodine Fumarate Extended-release tablets, 4mg and 8mg) is indicated to decrease the symptoms of overactive bladder.
For the original version including any supplementary images or video, visit http://www.pharmaceuticalonline.com/doc/fda-news-roundup-biogen-idec-gsk-roche-and-more-0001?atc~c=771+s=773+r=001+l=a

Provectus Biopharmaceuticals Updates Market on Business Developments - Yahoo Finance

A heavy emollient cream or ointment can soothe painfully dry skin and lock the moisture in. But if you need a cheap fix in a pinch, you could rub in a little cooking oil, shortening, olive oil, or coconut oil. Use medicated creams or rubs. Prescription corticosteroid creams you can get from your dermatologist can ease painful inflammation during a flare.
For the original version including any supplementary images or video, visit http://www.webmd.com/skin-problems-and-treatments/psoriasis/features/ways-ease-psoriasis-pain?src=RSS_PUBLIC

Celgene CEO Says Early-Stage Partnerships Begin to Show Promise - Bloomberg Business

Additionally, the Company has received notification of allowance from the European Patent Office for its patent application protecting the synthetic process used to produce the small molecule Rose Bengal, and an issued patent from the Japanese Patent Office for the same intellectual property. The pending European and Chinese patents and issued Japanese patent cover the same process as the one granted by the US Patent Office in September 2013, as U.S. Patent 8,530,675, Process for the Synthesis of 4,5,6,7-tetrachloro-3,6-dihydroxy-2,4,5,7-tetraiodo-3H-spiro[isobenzofuran-1,9-xanthen]-3-one (Rose Bengal) and Related Xanthenes. About Provectus Biopharmaceuticals, Inc. Provectus Biopharmaceuticals, Inc. specializes in developing oncology and dermatology therapies. PV-10, its novel investigational drug for cancer, is designed for injection into solid tumors (intralesional administration), thereby reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/provectus-biopharmaceuticals-updates-market-business-120000406.html

FDA News Roundup Biogen Idec GSK Roche And More

SolarWinds (SWI) announced it will be hosting a joint channel partner event with Spire Solutions, a cream psoriasis leader in value-added product distribution in the Middle East, in Dubai on April 12, 2015. Miele & Cie. KG announced a proof-of-concept study based on Microsoft (MSFT) Azure Internet of Things services that will help usher in the next generation of smart appliances and home cooking. The concept will allow home users to program their ovens to ensure their meals will come out perfectly cooked, providing an exceptional customer experience.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/inplay-briefing-com-075709631.html

Don't be the product, buy the product!